Department of Radiology

Publications

2023

Gao Y, Wang S, Xin H, Feng M, Zhang Q, Sui C, et al. Disrupted Gray Matter Networks Associated with Cognitive Dysfunction in Cerebral Small Vessel Disease. Brain Sci. 2023;13(10).

Sze C, Brant A, Johnson JP, Singh Z, DeMeo G, Moryousef J, et al. The role of quantitative MRI-based prostate zonal parameters in predicting clinically significant prostate cancer A U.S. cohort. Can Urol Assoc J. 2023;17(7):E182-E188.

Grover SB, Malhotra S, Pandey S, Grover H, Kale R, Devra AG. Erratum to "Imaging diagnosis of a giant choledochal cyst in an infant" [Radiology Case Reports 17 (2022) 404-411]. Radiol Case Rep. 2023;18(2):735.

Butler T. Letter to the Editor: Intense Exercise and Associated Blood-Brain Barrier Leakiness and Systemic Inflammation at the Time of Brain Injury May Be Relevant to Understanding Why Only Sports-Related Concussions Are Assoc. W/ Chronic Traumatic Encephalopathy. J Neurotrauma. 2023;40(11-12):1255-1256.

Ivanidze J, Nordvig AS, Fajardo AR, Tsiouris AJ, Chiang GC, Osborne JR. Medicare Coverage of Amyloid PET: Implications for Clinical Practice. AJNR Am J Neuroradiol. 2023;44(11):E45.

Tan N, Pollock JR, Margolis DJ, Padhani AR, Tempany C, Woo S, et al. Management of Patients With a Negative Multiparametric Prostate MRI Examination: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2023.

Shin T, Lee H-, Zun Z, Jang J. Spatially and velocity-selective magnetization preparation for noncontrast-enhanced peripheral MR angiography. NMR Biomed. 2023;36(7):e4901.

Limberg J, Egan CE, Gray KD, Singh M, Loewenstein Z, Yang Y, et al. Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma. Mol Cancer Res. 2023;21(5):397-410.

Bantugan MA, Xian H, Solomon V, Lee M, Cai Z, Wang S, et al. Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness. J Lipid Res. 2023;64(6):100354.

Subramanian K, Stangl-Kremser J, Sawoszczyk L, Avlonitis V, Gernerd A, Nixon K, et al. α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States. J Nucl Med Technol. 2023;51(3):215-219.